X4 Pharmaceuticals
XFOR
XFOR
79 hedge funds and large institutions have $358M invested in X4 Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
88% more funds holding
Funds holding: 42 → 79 (+37)
30.3% more ownership
Funds ownership: 71.98% → 102.28% (+30%)
Holders
79
Holding in Top 10
4
Calls
$1.25M
Puts
–
Top Buyers
| 1 | +$30.9M | |
| 2 | +$29.8M | |
| 3 | +$22.9M | |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
+$21.1M |
| 5 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
+$20.1M |
Top Sellers
| 1 | -$3.19M | |
| 2 | -$1.68M | |
| 3 | -$1.18M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$566K |
| 5 |
Renaissance Technologies
New York
|
-$65.6K |
